title: Mucosal relapse one year after complete remission of cutaneous sporotrichoid leishmaniasis due to Leishmania braziliensis.
authors.affiliation: Department of Dermatology.
authors.forename: Angeliki A
authors.initials: AA
authors.lastname: Ntasou
authors.affiliation: Department of Haematology and Oncology.
authors.forename: Hans
authors.initials: H
authors.lastname: Grummich
authors.affiliation: Institute of Microbiology and Hygiene.
authors.forename: Klaus
authors.initials: K
authors.lastname: Fischer
authors.affiliation: Department of Dermatology.
authors.forename: Vera
authors.initials: V
authors.lastname: Baur
authors.affiliation: Department of Otolaryngology, Paracelsus Medical University Nuernberg, Prof.-Ernst-Nathan. Str. 1, 90419 Nürnberg, Germany.
authors.forename: Viktor
authors.initials: V
authors.lastname: Bonkowsky
authors.affiliation: Department of Haematology and Oncology.
authors.forename: Josef
authors.initials: J
authors.lastname: Birkmann
authors.affiliation: Department of Dermatology.
authors.forename: Erwin S
authors.initials: ES
authors.lastname: Schultz
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D006801:Humans; D007892:Leishmania braziliensis; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000469:parasitology; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000469:parasitology; D010303:Paromomycin / Q000627:therapeutic use; D010612:Pharyngitis / Q000188:drug therapy* / Q000469:parasitology*; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000627:therapeutic use; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine; D010303:Paromomycin; D000666:Amphotericin B